Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Christine M Cutillo"'
Autor:
Keith A Crandall, Christine M Cutillo, Ainslie Tisdale, Mahdi Baghbanzadeh, Reva L Stidd, Manpreet S Khural, Laurie J Hartman, Jeff Greenberg, Kevin B Zhang, Ali Rahnavard
Publikováno v:
BMJ Public Health, Vol 2, Iss 1 (2024)
Objective The study capitalised on national insurance claims data to gather information on patient characteristics and associated costs to better understand the diagnosis and treatment of rare diseases (RDs).Materials and methods Data from the Health
Externí odkaz:
https://doaj.org/article/a8d9db16d5af415998d3185910c758e9
Publikováno v:
EMBO Molecular Medicine, Vol 11, Iss 5, Pp 1-7 (2019)
Abstract Rare diseases, which affect over 350 million people worldwide and frequently go undiagnosed or misdiagnosed for years, suffer from sparse and dispersed medical knowledge leading to even rarer approved and effective therapeutic options for pa
Externí odkaz:
https://doaj.org/article/18d94c76875644f1a362449cf8bf26d7
Autor:
Ainslie Tisdale, Christine M. Cutillo, Ramaa Nathan, Pierantonio Russo, Bryan Laraway, Melissa Haendel, Douglas Nowak, Cindy Hasche, Chun-Hung Chan, Emily Griese, Hugh Dawkins, Oodaye Shukla, David A. Pearce, Joni L. Rutter, Anne R. Pariser
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 16, Iss 1, Pp 1-18 (2021)
Abstract Background Rare diseases (RD) are a diverse collection of more than 7–10,000 different disorders, most of which affect a small number of people per disease. Because of their rarity and fragmentation of patients across thousands of differen
Externí odkaz:
https://doaj.org/article/bd3dbd832fd6404ca21a136660f71696
Autor:
Christine M. Cutillo, Karlie R. Sharma, Luca Foschini, Shinjini Kundu, Maxine Mackintosh, Kenneth D. Mandl, MI in Healthcare Workshop Working Group
Publikováno v:
npj Digital Medicine, Vol 3, Iss 1, Pp 1-5 (2020)
Machine Intelligence (MI) is rapidly becoming an important approach across biomedical discovery, clinical research, medical diagnostics/devices, and precision medicine. Such tools can uncover new possibilities for researchers, physicians, and patient
Externí odkaz:
https://doaj.org/article/83ce70f92f1146a5ac7b2a83189e0791
Autor:
Christine M. Cutillo, Hugh Dawkins, Oodaye Shukla, David A. Pearce, Pierantonio Russo, Cindy Hasche, Douglas Nowak, Ramaa Nathan, Ainslie Tisdale, Bryan Laraway, Melissa Haendel, Joni L. Rutter, Emily R. Griese, Chun-Hung Chan, Anne Pariser
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 16, Iss 1, Pp 1-18 (2021)
Orphanet Journal of Rare Diseases
Orphanet Journal of Rare Diseases
Background Rare diseases (RD) are a diverse collection of more than 7–10,000 different disorders, most of which affect a small number of people per disease. Because of their rarity and fragmentation of patients across thousands of different disorde
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8ba6cd02e0788a77a4e845e0a7c8e66
https://doaj.org/article/bd3dbd832fd6404ca21a136660f71696
https://doaj.org/article/bd3dbd832fd6404ca21a136660f71696
Autor:
Christine M. Cutillo, Angela Navarrete-Opazo, Ainslie Tisdale, Sheldon R. Garrison, Maharaj Singh
Publikováno v:
Genetics in Medicine
PURPOSE The vast majority of rare diseases (RDs) are complex, disabling, and life-threatening conditions with a genetic origin. RD patients face significant health challenges and limited treatments, yet the extent of their impact within health care i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96d75468db7c9032a5e70a6501dbbc48
http://europepmc.org/articles/PMC8553605
http://europepmc.org/articles/PMC8553605
Autor:
Kanny K. Wan, Danielle Davis, Taylor N. Lee, Stephanie L. Ford-Scheimer, Antonio L. Andreu, Florence Bietrix, Justin Bryans, Marco T. Castro, Nobuyoshi Chiba, Jessica M. Faupel-Badger, Brittany Haynes, Ryutaro Hirasawa, Carlos M. Morel, Thiago Moreno L. Souza, David Morrow, Trent Munro, Stuart Newman, Anton E. Ussi, Poliana B. Zorzal, Matthew D. Hall, Donald C. Lo, Christine M. Cutillo
Publikováno v:
Nature Reviews Drug Discovery
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87074b38b5e8f64a8caab0fcae942d91
https://doi.org/10.1038/d41573-022-00020-6
https://doi.org/10.1038/d41573-022-00020-6
Autor:
Ana Rath, Anneliene H. Jonker, Paul Lasko, Hugh Dawkins, Gareth Baynam, Hanns Lochmüller, Virginie Hivert, Yann Le Cam, Ruxandra Draghia-Akli, Christopher P. Austin, Lilian P.L. Lau, Christine M. Cutillo, Kym M. Boycott, Petra Kaufmann
Publikováno v:
Clinical and Translational Science. 11:11-20
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bfa3c1c147f0f514d5337f837111fe60
https://doi.org/10.1111/cts.12501
https://doi.org/10.1111/cts.12501
Autor:
Gareth Baynam, Carlo Incerti, Daria Julkowska, Hanns Lochmüller, Christine M. Cutillo, Ruxandra Draghia-Akli, Christopher P. Austin, Petra Kaufmann, Sharon F. Terry, Anneliene H. Jonker, Lu Wang, Lilian P.L. Lau, Béatrice de Montleau, Kym M. Boycott, Domenica Taruscio, David Thomson, Diego Ardigò, Makoto Suematsu, Hugh Dawkins, Virginie Hivert, Irene Norstedt, Ana Rath
Publikováno v:
Clinical and Translational Science. 11:21-27
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1ace0837dfafafd77b799eb75aac2f95
https://doi.org/10.1111/cts.12500
https://doi.org/10.1111/cts.12500
Publikováno v:
EMBO Molecular Medicine
Rare diseases, which affect over 350 million people worldwide and frequently go undiagnosed or misdiagnosed for years, suffer from sparse and dispersed medical knowledge leading to even rarer approved and effective therapeutic options for patients. A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2e86544fcc5e528caf04794add04ab6
http://europepmc.org/articles/PMC6505568
http://europepmc.org/articles/PMC6505568